Physician

Mario J Lopez, MD

According to 2025 Medicare claims, Mario Lopez, MD (NPI: 1710990882) practices cardiology in the Punta Gorda, FL market, with the plurality of this provider's patient population coming from Charlotte, FL. This provider's primary affiliated billing organization is CHARLOTTE HEART & VASCULAR CENTER (NPI: 1477266971; TIN: 921354205) and primary practice location at 33948-4017.

Lopez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 974 traditional Medicare patients, billed 6,094 HCPCS/CPT codes, and received $478,329 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 7,487 prescription claims across 1,105 beneficiaries totaling $1,787,865 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 44 claims. Open Payments data shows 102 records totaling $235,421. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $865,659 to $478,329. In contrast, Part D prescription costs have risen steadily, from $701,964 to $1,787,865. For DME billing, this smaller-volume category fell sharply in recent years, from $56,981 to $2,291.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,117	13,540	$865,659
2016	2,075	15,414	$924,519
2017	2,110	10,104	$768,731
2018	2,521	10,276	$715,903
2019	3,110	12,280	$772,595
2020	2,733	10,612	$621,467
2021	2,607	9,689	$601,232
2022	1,894	7,005	$539,955
2023	1,213	5,443	$393,168
2024	974	6,094	$478,329

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,076	6,443	$701,964
2016	1,191	7,513	$1,054,103
2017	1,392	9,377	$1,214,870
2018	1,456	9,635	$1,336,591
2019	1,549	10,487	$1,458,398
2020	1,553	11,356	$1,781,950
2021	1,414	10,009	$1,819,051
2022	1,303	9,384	$1,946,134
2023	1,141	5,936	$1,319,027
2024	1,105	7,487	$1,787,865

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	48	$56,871
2016	12	37	$51,063
2017	N/R	29	$60,156
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	22	$1,067
2021	N/R	24	$1,245
2022	N/R	44	$2,291
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	190	195	$319
93880	Ultrasound of both sides of head and neck blood flow	290	300	$131
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	540	613	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	673	1,333	$88
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	474	597	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	611	38,943	$733,891
Entresto	Sacubitril/Valsartan	165	11,375	$231,142
Repatha Sureclick	Evolocumab	195	10,592	$199,332
Xarelto	Rivaroxaban	99	6,773	$121,836
Multaq	Dronedarone Hcl	49	3,820	$97,086

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	99	$2,244	Philips North America LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$233,177	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mario J. Lopez, MD?

Tedicare shows public-source Medicare data for Mario J. Lopez, MD (NPI 1710990882), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mario J. Lopez, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mario J. Lopez, MD?

Mario J. Lopez, MD is linked to CHARLOTTE HEART & VASCULAR CENTER (billing NPI 1477266971) in the available physician profile data.

Does Mario J. Lopez, MD have Open Payments data?

Mario J. Lopez, MD has 102 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.